Avanir Pharmaceuticals closes community offering of 20,930,000 shares of common stock Avanir Pharmaceuticals, Inc.00 per share, before underwriting special discounts ?caverta information caverta.biz . J.P. Morgan, Deutsche Lender Securities and BofA Merrill Lynch acted as joint book-operating managers for the providing. Piper JMP and Jaffray Securities acted as co-managers for the supplying. Gross arises from the providing are $230,230,000 before deducting underwriting special discounts and estimated offering expenditures payable by Avanir. Avanir intends to utilize the net proceeds from the general public providing for general corporate reasons, such as, but are not really limited by, funding NUEDEXTA commercial actions, financing our ongoing and potential clinical trials, financing the commercial start of AVP-825, if authorized, and for administrative and general expenses.